Showing results (401-410 of 630) with videos related to
Sort By:
Pageof 63
American Journal of Hematology|June 5, 2007
Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokineStephen K Richardson, Sarah B Newton, Tami L Bach, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II studyD R Parkinson, J S Abrams, P H Wiernik, et al.The Journal of Infectious Diseases|February 1, 1993
Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasiB J Holaday, M M Pompeu, T Evans, et al.Science (New York, N.Y.)|September 6, 2008
Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylationWeijun Pan, Sun-Cheol Choi, He Wang, et al.Plos One|August 13, 2013
RhoA is essential for maintaining normal megakaryocyte ploidy and platelet generationAae Suzuki, Jae-Won Shin, Yuhuan Wang, et al.Molecular and Cellular Biology|August 21, 2019
PIKfyve Deficiency in Myeloid Cells Impairs Lysosomal Homeostasis in Macrophages and Promotes Systemic Inflammation in MiceSang Hee Min, Aae Suzuki, Lehn Weaver, et al.Academic Radiology|September 10, 2019
Contrast Enhanced Digital Mammography (CEDM) Helps to Safely Reduce Benign Breast Biopsies for Low to Moderately Suspicious Soft Tissue LesionsMargarita L Zuley, Andriy I Bandos, Gordon S Abrams, et al.Journal of Clinical Medicine|December 30, 2025
Prostate Artery Embolization vs. Holmium Laser Enucleation of the Prostate: A Matched Pair Analysis of Functional Outcomes and ComplicationsSimon Hannes Friedrich Leschik, Robert Große Siemer, Friedrich-Carl von Rundstedt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN)Holly A Massett, Grace Mishkin, Jeffrey A Moscow, et al.IRB|February 1, 2019
A Randomized Controlled Study Comparing the National Cancer Institute's Original and Revised Consent Form TemplatesHolly A Masset, Michelle Hiser, Nancy L Atkinson, et al.Pageof 63